Search

Your search keyword '"Easton, Douglas F"' showing total 3,631 results

Search Constraints

Start Over You searched for: Author "Easton, Douglas F" Remove constraint Author: "Easton, Douglas F"
3,631 results on '"Easton, Douglas F"'

Search Results

3. Germline copy number variants and endometrial cancer risk

4. Understanding the genetic complexity of puberty timing across the allele frequency spectrum

5. Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization

7. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

8. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

10. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

11. Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum

12. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

13. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

14. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

15. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

16. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

17. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

19. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

20. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

21. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

22. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

23. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

24. Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 families

25. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

26. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women

27. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

29. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

30. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.

31. Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women

32. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumBreast Cancer Risk Factors and Survival By Tumor Subtype

33. Improving reporting standards for polygenic scores in risk prediction studies

34. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

35. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry

36. Personalized early detection and prevention of breast cancer: ENVISION consensus statement

37. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

38. The effect of sample size on polygenic hazard models for prostate cancer

39. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data

40. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

41. Pan-cancer analysis of whole genomes

42. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

43. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk

44. The impact of coding germline variants on contralateral breast cancer risk and survival

46. A saturated map of common genetic variants associated with human height

47. Relevance of the MHC region for breast cancer susceptibility in Asians

48. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

49. BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

50. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

Catalog

Books, media, physical & digital resources